Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Experimental Cell Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.YEXCR.2004.08.013PMID 15541720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evidence for a cancer-specific switch at the CDK4 promoter with loss of control by both USF and c-Myc

  2004cited by this paper
• Molecular Characterization and Role of Bovine Upstream Stimulatory Factor 1 and 2 in the Regulation of the Prostaglandin G/H Synthase-2 Promoter in Granulosa Cells*

  2004cited by this paper
• Transcriptional repression by Myc.

  2003cited by this paper
• Mechanisms of c-myc-mediated transcriptional repression of growth arrest genes.

  2003cited by this paper
• Diminished milk synthesis in upstream stimulatory factor 2 null mice is associated with decreased circulating oxytocin and decreased mammary gland expression of eukaryotic initiation factors 4E and 4G.

  2003cited by this paper
• The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer Cells*

  2003cited by this paper
• Gastroprotective peptide trefoil factor family 2 gene is activated by upstream stimulating factor but not by c-Myc in gastrointestinal cancer cells

  2002cited by this paper
• Upstream stimulating factor‐1 (USF1) and USF2 bind to and activate the promoter of the adenomatous polyposis coli (APC) tumor suppressor gene

  2001cited by this paper
• c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

  2001cited by this paper
• The Myc/Max/Mad network and the transcriptional control of cell behavior.

  2000cited by this paper
• The USF proteins regulate transcription of the follicle-stimulating hormone receptor but are insufficient for cell-specific expression.

  2000cited by this paper
• Cell-Type-Dependent Activity of the Ubiquitous Transcription Factor USF in Cellular Proliferation and Transcriptional Activation

  1999cited by this paper
• Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells

  1999cited by this paper
• Reversible tumorigenesis by MYC in hematopoietic lineages.

  1999cited by this paper
• Loss of USF transcriptional activity in breast cancer cell lines

  1999cited by this paper
• Isolation and initial characterization of the BRCA2 promoter

  1999cited by this paper
• Control of cell proliferation by Myc.

  1998cited by this paper
• Overlapping roles and asymmetrical cross-regulation of the USF proteins in mice.

  1998cited by this paper
• Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter.

  1998cited by this paper
• Differential Roles of Upstream Stimulatory Factors 1 and 2 in the Transcriptional Response of Liver Genes to Glucose*

  1998cited by this paper
• A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding.

  1997cited by this paper
• Use of tetracycline-controlled gene expression systems to study mammalian cell cycle.

  1997cited by this paper
• Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains

  1996cited by this paper
• Mouse USF1 gene cloning: comparative organization within the c-myc gene family

  1996cited by this paper
• Antiproliferative properties of the USF family of helix-loop-helix transcription factors.

  1996cited by this paper
• Base preferences for DNA binding by the bHLH-Zip protein USF: effects of MgCl2 on specificity and comparison with binding of Myc family members.

  1994cited by this paper
• c‐Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.

  1994cited by this paper
• Archaic structure of the gene encoding transcription factor USF.

  1994cited by this paper
• Repression of cyclin D1: a novel function of MYC.

  1994cited by this paper
• Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells.

  1994cited by this paper
• The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene.

  1993cited by this paper
• Human transcription factor USF stimulates transcription through the initiator elements of the HIV‐1 and the Ad‐ML promoters.

  1993cited by this paper
• Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

  1992cited by this paper
• The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer.

  1990cited by this paper
• Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts

  1986cited by this paper
• Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene

  1985cited by this paper
• Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells

  1982cited by this paper

• Knockdown of USF1 and USF2 drives prolonged changes in the gene expression response of M12-5B3 cells to DNA damage

  2025cites this paper
• Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma

  2025cites this paper
• E-box binding transcription factors in cancer

  2023cites this paper
• hsa-miR-875-5p inhibits tumorigenesis and suppresses TGF-β signalling by targeting USF2 in gastric cancer

  2022cites this paper
• USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling

  2022cites this paper
• Has-miR-875-5p Inhibits Tumorigenesis by Targeting USF2 via TGF-β Signaling Pathway in Gastric Cancer

  2021cites this paper
• Induction of Pluripotent and Trophectoderm States

  2020cites this paper
• Comparative parallel multi-omics analysis during the induction of pluripotent and trophectoderm states

  2020cites this paper
• Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer

  2015cites this paper
• Integration of proteomic and transcriptomic profiles identifies a novel PDGF-MYC network in human smooth muscle cells

  2014cites this paper
• FGF10: Type III Epithelial Mesenchymal Transition and Invasion in Breast Cancer Cell Lines

  2014cites this paper
• Construction of a novel oligonucleotide array‐based transcription factor interaction assay platform and its uses for profiling STAT1 cofactors in mouse fibroblast cells

  2013cites this paper
• Role of Helix-Loop-Helix Proteins during Differentiation of Erythroid Cells

  2011cites this paper
• Calpeptin Increases the Activity of Upstream Stimulatory Factor and Induces High Level Globin Gene Expression in Erythroid Cells*

  2009cites this paper
• Role of altered pH homeostasis and hypoxia in the phenotypic changes of cancer cells

  2009cites this paper
• Intricate gene regulatory networks of helix‐loop‐helix (HLH) proteins support regulation of bone‐tissue related genes during osteoblast differentiation

  2008cites this paper
• Max is acetylated by p300 at several nuclear localization residues.

  2007cites this paper
• Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promoters.

  2007cites this paper
• Endoproteolytic processing of C-terminally truncated NF-κB2 precursors at κB-containing promoters

  2007cites this paper
• Identification of USF Binding Sites in the Human IGFBP3 Promoter and Potential Implication of Adjacent Single Nucleotide Polymorphisms and Responsiveness to Insulin

  2007cites this paper
• Hypoxia upregulates carcinoembryonic antigen expression in cancer cells

  2007cites this paper
• Identification of upstream stimulatory factor binding sites in the human IGFBP3 promoter and potential implication of adjacent single-nucleotide polymorphisms and responsiveness to insulin.

  2007cites this paper
• Tumor-suppression function of transcription factor USF2 in prostate carcinogenesis

  2006cites this paper
• Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.

  2005cites this paper
• Roles for USF‐2 in lung cancer proliferation and bronchial carcinogenesis

  2005cites this paper
• Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells

  2005cites this paper